Investigational drug · Phase 2
HRS-1301
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hyperlipidemia.
Phase 2Last checked: Nov 20, 2026Latest source record: Dec 12, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
5
Any phase or sponsor naming "HRS-1301"
First trial start
2025
Nov 25, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "HRS-1301", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hyperlipidemia
Approved drugs for the same conditions: High cholesterol · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "HRS-1301" as an intervention, largest first.
- A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With DyslipidemiaPivotal-lookingRecruiting
Shandong Suncadia Medicine Co., Ltd.Industry
NCT07229937 · 189 participants (planned) · Start Nov 25, 2025 · Primary completion Aug 2026
Drug: HRS-1301; HRS-1301 and 3 more · For: Hyperlipidemia
Sites: Harbin, China
Shandong Suncadia Medicine Co., Ltd.Industry
NCT06857253 · 84 participants · Start Mar 18, 2025 · Primary completion Aug 12, 2025
Drug: HRS-1301; HRS-1301 placebo · For: Hyperlipidemia
Sites: Guangzhou, China
Shandong Suncadia Medicine Co., Ltd.Industry
NCT07322016 · 36 participants · Start Jan 13, 2026 · Primary completion Aug 4, 2026
Drug: HRS-1301 Tablet · For: Hyperlipidemias
Sites: Chengdu, China
Shandong Suncadia Medicine Co., Ltd.Industry
NCT07608705 · 16 participants · Start Jun 8, 2026 · Primary completion Aug 24, 2026
Drug: HRS-1301 Tablets; Atorvastatin Calcium Tablets and 1 more · For: Hyperlipidemias
Sites: Jinan, China
Shandong Suncadia Medicine Co., Ltd.Industry
NCT07097831 · 16 participants · Start Oct 9, 2025 · Primary completion Nov 7, 2025
Drug: HRS-1301 Tablets; Rosuvastatin Calcium Tablets · For: Hyperlipidemia
Sites: Suzhou, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Hyperlipidemia
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.